ALT5 Sigma Seeks Shareholder Nod for Massive Share Increase, Investor Influence
Ticker: ALTS · Form: DEF 14A · Filed: Sep 26, 2025 · CIK: 862861
Sentiment: bearish
Topics: Shareholder Meeting, Stock Dilution, Private Placement, Corporate Governance, Authorized Shares, Warrant Exercise, Nasdaq Compliance
Related Tickers: ALTS
TL;DR
**ALTS is gearing up for massive dilution and increased investor control; existing shareholders should brace for impact.**
AI Summary
ALT5 Sigma Corporation (ALTS) is seeking stockholder approval for several critical actions following a private placement that closed on August 12, 2025. The company proposes to issue 119,000,000 shares of common stock upon the exercise of warrants held by World Liberty Financial, Inc., the Lead Investor, as per a securities purchase agreement dated August 11, 2025. Additionally, ALTS plans to appoint a second director selected by World Liberty Financial, Inc. to its Board of Directors. A significant proposal involves increasing the total authorized shares of common stock from 200,000,000 to 2,000,000,000, a tenfold increase. These actions are necessary to comply with Nasdaq Listing Rule 5635 and facilitate future capital raises. The Board of Directors unanimously recommends a 'FOR' vote on all four proposals, including the authorization for adjournments or postponements of the Special Meeting scheduled for October 10, 2025.
Why It Matters
This DEF 14A filing reveals ALT5 Sigma's strategic pivot to accommodate a significant private placement and future capital needs, directly impacting existing investors through potential dilution. The proposed issuance of 119,000,000 shares and the tenfold increase in authorized shares to 2,000,000,000 signal a clear intent for substantial future fundraising, which could be a double-edged sword for shareholders. While it provides capital for growth, it also introduces considerable dilution risk. The appointment of a second director from World Liberty Financial, Inc. suggests increased influence from the Lead Investor, potentially shifting governance dynamics and competitive strategy within the digital asset sector.
Risk Assessment
Risk Level: high — The proposal to increase authorized shares from 200,000,000 to 2,000,000,000 represents a 900% increase, indicating a high potential for significant future dilution. Furthermore, the issuance of 119,000,000 shares to World Liberty Financial, Inc. upon warrant exercise, combined with the appointment of a second director from the Lead Investor, suggests a substantial shift in ownership and control, posing a high risk to minority shareholders.
Analyst Insight
Investors should carefully consider the long-term dilution implications of the proposed 900% increase in authorized shares. While the capital infusion from the private placement is positive, the potential for future share issuances could significantly depress per-share value. Existing shareholders should vote 'FOR' the proposals if they believe the capital infusion and strategic partnership outweigh the dilution risk, or 'AGAINST' if they prioritize current share value and control.
Key Numbers
- 119,000,000 — Shares of common stock to be issued (Upon exercise of warrants by World Liberty Financial, Inc.)
- 200,000,000 — Current authorized shares of Common Stock (Proposed to be increased to 2,000,000,000)
- 2,000,000,000 — Proposed authorized shares of Common Stock (Represents a tenfold increase from current authorization)
- August 12, 2025 — Record Date (For determining stockholders entitled to vote at the Special Meeting)
- October 10, 2025 — Special Meeting Date (When stockholders will vote on the proposals)
- 109,620,596 — Common Stock shares outstanding (As of the Record Date, August 12, 2025)
- 883,667 — Voting Preferred Stock shares outstanding (Comprised of Series B, I, Q, and S Preferred Stock as of August 12, 2025)
- 34,207 — Series B Preferred Stock shares outstanding (As of the Record Date, August 12, 2025)
- 732,460 — Series Q Preferred Stock shares outstanding (As of the Record Date, August 12, 2025)
- 100,000 — Series S Preferred Stock shares outstanding (As of the Record Date, August 12, 2025)
Key Players & Entities
- ALT5 Sigma Corporation (company) — Registrant seeking stockholder approval
- World Liberty Financial, Inc. (company) — Lead Investor in the private placement
- Tony Isaac (person) — Corporate Secretary of ALT5 Sigma Corporation
- Nasdaq Listing Rule 5635 (regulator) — Rule requiring stockholder approval for certain issuances
- Equiniti Trust Company, LLC (company) — Transfer agent for ALT5 Sigma Corporation
- Broadridge Financial Services, Inc. (company) — Independent tabulator for the Special Meeting
- Jonathan Hugh (person) — Proxyholder for voting on other business
- Zachary Witkoff (person) — Proxyholder for voting on other business
- $0.001 (dollar_amount) — Par value per share of Common Stock
- SEC (regulator) — Securities and Exchange Commission
FAQ
What is ALT5 Sigma Corporation asking shareholders to approve at the Special Meeting?
ALT5 Sigma Corporation is asking shareholders to approve four proposals: the issuance of 119,000,000 shares of common stock to World Liberty Financial, Inc., the appointment of a second director selected by World Liberty Financial, Inc., an increase in authorized common stock from 200,000,000 to 2,000,000,000 shares, and the approval of adjournments or postponements of the Special Meeting.
When is ALT5 Sigma's Special Meeting of Stockholders?
The Special Meeting of Stockholders for ALT5 Sigma Corporation is scheduled for October 10, 2025, at 10:00 a.m. Pacific Time. It will be held in a virtual-only format via live webcast at www.virtualshareholdermeeting.com/ALTS2025SM.
What is the significance of increasing ALT5 Sigma's authorized shares to 2,000,000,000?
Increasing ALT5 Sigma's authorized shares from 200,000,000 to 2,000,000,000 provides the company with significantly more flexibility to issue new shares in the future. This could facilitate further capital raises, mergers, or acquisitions, but also carries the risk of substantial dilution for existing shareholders if new shares are issued.
Who is World Liberty Financial, Inc. and what is their role in ALT5 Sigma's proposals?
World Liberty Financial, Inc. is identified as the 'Lead Investor' in a private placement that closed on August 12, 2025. They are set to receive 119,000,000 shares of ALT5 Sigma common stock upon warrant exercise and will also appoint a second director to ALT5 Sigma's Board of Directors, indicating a significant investment and increased influence.
How does Nasdaq Listing Rule 5635 relate to ALT5 Sigma's proposals?
Nasdaq Listing Rule 5635 requires stockholder approval for certain transactions, including the issuance of securities in connection with a private placement that exceeds 20% of the outstanding common stock or voting power, or the issuance of securities that would result in a change of control. ALT5 Sigma is seeking approval for the issuance of 119,000,000 shares and the appointment of a director to comply with this rule.
What is the record date for voting at ALT5 Sigma's Special Meeting?
The record date for determining stockholders entitled to notice of and to vote at ALT5 Sigma's Special Meeting is the close of business on August 12, 2025. Only holders of record of Common Stock and Voting Preferred Stock on this date will be eligible to vote.
How many shares of common stock were outstanding for ALT5 Sigma on the record date?
As of the close of business on the record date, August 12, 2025, there were 109,620,596 shares of ALT5 Sigma Corporation's Common Stock issued and outstanding.
What is a 'broker non-vote' and how does it affect ALT5 Sigma's proposals?
A 'broker non-vote' occurs when a broker, bank, or other nominee does not receive voting instructions from a beneficial owner for a 'non-routine' matter. For ALT5 Sigma's proposals (Issuance, Appointment, Authorized Shares, and Adjournment), which are considered 'non-routine,' broker non-votes will be counted for quorum purposes but will not affect the outcome of the vote on these specific proposals.
What is the Board of Directors' recommendation for voting on the proposals?
The Board of Directors of ALT5 Sigma Corporation unanimously recommends that stockholders vote 'FOR' all four proposals: the Issuance Proposal, the Appointment Proposal, the Authorized Shares Proposal, and the Adjournment Proposal.
Can ALT5 Sigma stockholders change their vote after submitting a proxy?
Yes, ALT5 Sigma stockholders can revoke their proxy at any time before the final vote at the Special Meeting. This can be done by submitting a later-dated proxy card, granting a subsequent proxy by telephone or internet, sending a timely written notice of revocation to the Corporate Secretary, or by attending the Special Meeting virtually and voting electronically.
Risk Factors
- Nasdaq Listing Rule Compliance [high — regulatory]: The company is seeking stockholder approval to issue 119,000,000 shares and increase authorized shares to 2,000,000,000 to comply with Nasdaq Listing Rule 5635. Failure to obtain approval could jeopardize the company's listing on Nasdaq.
- Dilution from Warrant Exercise [high — financial]: The exercise of 119,000,000 warrants by World Liberty Financial, Inc. will significantly dilute existing shareholders. This is a direct consequence of the private placement closed on August 12, 2025.
- Need for Future Capital Raises [medium — financial]: The proposed tenfold increase in authorized shares from 200,000,000 to 2,000,000,000 is intended to facilitate future capital raises. This indicates a potential ongoing need for external funding.
- Board Composition Changes [medium — operational]: The appointment of a second director selected by World Liberty Financial, Inc. will alter the board's composition. This could influence strategic decision-making and corporate governance.
Industry Context
ALT5 Sigma Corporation operates in the fintech sector, specifically focusing on digital asset trading and related financial technology solutions. The industry is characterized by rapid innovation, increasing regulatory scrutiny, and a competitive landscape with both established financial institutions and emerging technology firms. Companies in this space often require significant capital for development, compliance, and market expansion.
Regulatory Implications
The company's proposals are directly driven by Nasdaq Listing Rule 5635, which mandates shareholder approval for significant equity issuances. Failure to secure approval for the share issuance and increased authorized shares could lead to delisting from Nasdaq, severely impacting liquidity and investor confidence.
What Investors Should Do
- Vote 'FOR' Proposal 1 (Issuance of Shares): Approve the issuance of 119,000,000 shares upon warrant exercise to comply with Nasdaq rules and finalize the private placement.
- Vote 'FOR' Proposal 3 (Authorized Shares Increase): Approve the increase of authorized shares from 200,000,000 to 2,000,000,000 to facilitate warrant exercise and future capital needs.
- Review the impact of potential dilution from the 119,000,000 share issuance on existing holdings.
- Understand that the Board recommends a 'FOR' vote on all four proposals.
Key Dates
- 2025-08-11: Securities Purchase Agreement Signed — This agreement outlines the terms for the private placement, including the warrants to be exercised.
- 2025-08-12: Private Placement Closed / Record Date — Marks the completion of the private placement and determines the stockholders eligible to vote at the Special Meeting.
- 2025-09-26: Proxy Materials Mailed — Informs stockholders about the upcoming Special Meeting and the proposals to be voted on.
- 2025-10-10: Special Meeting Date — Stockholders will vote on critical proposals, including share authorization and warrant exercise.
Glossary
- DEF 14A
- A proxy statement filed with the SEC by publicly traded companies to solicit shareholder votes on important corporate matters. (This document contains the proposals and information necessary for shareholders to make informed voting decisions.)
- Warrants
- Securities that give the holder the right, but not the obligation, to purchase a company's stock at a predetermined price within a specified timeframe. (The exercise of 119,000,000 warrants is a key proposal requiring shareholder approval.)
- Authorized Shares
- The maximum number of shares of stock that a corporation is legally permitted to issue, as specified in its charter. (The company is proposing a significant increase in authorized shares to accommodate warrant exercises and future financing.)
- Nasdaq Listing Rule 5635
- A rule requiring shareholder approval for certain equity issuances, typically when the issuance exceeds 20% of the outstanding shares or voting power. (The company needs shareholder approval for the proposed share issuance and increase in authorized shares to remain in compliance with Nasdaq rules.)
- Private Placement
- A sale of securities directly to a select group of investors, rather than through a public offering. (The recent private placement on August 12, 2025, is the catalyst for the proposals in this proxy statement.)
Year-Over-Year Comparison
This DEF 14A filing is focused on specific corporate actions related to a recent private placement and Nasdaq compliance, rather than a comprehensive annual review. Therefore, direct year-over-year comparisons of financial metrics like revenue, net income, or margins are not applicable in this context. The primary focus is on the structural changes and approvals needed to maintain Nasdaq listing and support future growth.
Filing Stats: 4,682 words · 19 min read · ~16 pages · Grade level 12.5 · Accepted 2025-09-26 06:02:35
Key Financial Figures
- $0.001 — 0 shares of our common stock, par value $0.001 per share (“Common Stock”),
- $750 million — urchase Agreement, the Company received $750 million of $WLFI tokens based on a price of $0.
- $0.20 — ion of $WLFI tokens based on a price of $0.20 per $WLFI token and issued to the Lead
- $7.50 — of Common Stock at a purchase price of $7.50 per share (the “PIPE Shares&rdquo
- $7.499 — t Shares”) at a purchase price of $7.499 per PIPE Pre-Funded Warrant. Each of th
- $8.25 — of Common Stock at an exercise price of $8.25 per share of Common Stock; (iii) 4,000,
- $9.00 — of Common Stock at an exercise price of $9.00 per share of Common Stock; and (iv) 4,0
- $9.75 — of Common Stock at an exercise price of $9.75 per share of Common Stock, subject to a
Filing Documents
- formdef14a.htm (DEF 14A) — 394KB
- proxy_001.jpg (GRAPHIC) — 719KB
- proxy_002.jpg (GRAPHIC) — 405KB
- 0001493152-25-015033.txt ( ) — 1942KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS 15 OTHER MATTERS 17 PROXY SOLICITATION AND COSTS 17 WHERE YOU CAN FIND MORE INFORMATION 17 APPENDIX A: CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF ALT5 SIGMA CORPORATION A-1 i ALT5 SIGMA CORPORATION 325 E. Warm Springs Road, Suite 102 Las Vegas, Nevada 89119 PROXY FOR SPECIAL MEETING OF STOCKHOLDERS TO BE HELD AT 10:00 A.M. PACIFIC TIME ON OCTOBER 10, 2025 INTRODUCTION This Proxy Statement is being furnished in connection with the solicitation of proxies by our board of directors (the “Board”) for use at the Special Meeting of Stockholders (the “Special Meeting”) of ALT5 Sigma Corporation, a Nevada corporation (the “Company”), and any postponements or adjournments thereof. The Special Meeting will be held on Friday, October 10, 2025 at 10:00 a.m. Pacific Time. The information provided under “ Questions and Answers About These Proxy Materials and Voting ” below is for your convenience only. You should read this entire Proxy Statement carefully. Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this Proxy Statement and references to our website address in this Proxy Statement are inactive textual references only. Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on October 10, 2025 We anticipate that this Proxy Statement, the Notice of Special Meeting of Stockholders, and the form of proxy card will be mailed to our stockholders commencing on or about September 26, 2025. We are using the “Full Set Delivery” method of providing proxy materials to stockholders. Because we have elected to utilize the “Full Set Delivery” option, we are delivering to all stockholders of record paper copies of this Proxy Statement and form of proxy card, as well as providing access to t